牛津大学新冠肺炎试验将研究53例感染后的中期第三阶段数据:调查员

2020-11-19 20:09

Oxford COVID-19 trial will look at interim Phase III data after 53 infections: investigator E6U世界播

牛津大学新冠肺炎试验将研究53例感染后的中期第三阶段数据:调查员E6U世界播


LONDON (Reuters) - Oxford University will start an initial analysis of data from its late-stage trial of the experimental COVID-19 vaccine it is developing with AstraZeneca after 53 infections among its volunteers, the study's chief investigator said on Thursday. E6U世界播

伦敦(路透社)-牛津大学(Oxford University)首席研究员周四表示,牛津大学将开始对其与阿斯利康(AstraZeneca)共同开发的实验性新冠肺炎疫苗的后期试验数据进行初步分析,此前该校志愿者中有53人感染。E6U世界播


The Oxford Vaccine Group's director, Andrew Pollard, said in a media briefing there were "lots of cases" of infections in its Phase III trial in Britain, Brazil and South Africa. E6U世界播

牛津疫苗集团(Oxford Vaccine Group)负责人安德鲁·波拉德(Andrew Pollard)在一次媒体吹风会上表示,在英国、巴西和南非进行的第三阶段试验中,感染病例“很多”。E6U世界播


The first two sets of interim data from vaccine trials from Pfizer and BioNTech last week and Moderna on Monday were released after more than 90 infections among volunteers. E6U世界播

辉瑞(Pfizer)和生物科技(BioNTech)上周以及周一发布的疫苗试验的前两组中期数据是在志愿者感染90多人后公布的。E6U世界播


Pfizer had planned to publish initial data after about 60 infections, but it exceeded its target after the big jump in infections recently in the United States. E6U世界播

辉瑞原本计划在大约60例感染后公布初步数据,但在美国最近感染人数大幅增加后,辉瑞超过了目标。E6U世界播


Pollard's comments came after data published on Thursday showed the Oxford/AstraZeneca vaccine in Phase II studies produced a strong immune response in older adults, suggesting that those at higher risk of serious illness and death from COVID-19 could be protected. E6U世界播

波拉德发表上述言论之前,周四公布的数据显示,牛津/阿斯利康(AstraZeneca)二期研究中的疫苗在老年人中产生了强烈的免疫反应,这表明那些因新冠肺炎而患重病和死亡风险较高的人可以得到保护。E6U世界播


Pollard said there was no attempt to release the study in the same week as those companies' data, the first from late-stage vaccine trials, but rather the study happened to be ready for publication. E6U世界播

波拉德说,并不打算在与这些公司的数据同一周公布这项研究,这是第一批来自晚期疫苗试验的数据,但恰好这项研究已经准备好发表了。E6U世界播


Earlier on Thursday, he said he expected Phase III data to be released by Christmas. E6U世界播

周四早些时候,他表示,他预计第三阶段数据将在圣诞节前发布。E6U世界播


The Phase III results showing efficacy of the vaccine will be released via AstraZeneca, in the same way they have been published by other drugmakers over the past week or so, Pollard said. E6U世界播

Pollard说,显示疫苗有效性的第三阶段结果将通过阿斯利康发布,与其他制药商在过去一周左右发布的结果相同。E6U世界播


He said the trial would also publish the findings in a peer-reviewed medical journal but initial data would likely be released before then. E6U世界播

他说,这项试验还将在同行评议的医学杂志上发表研究结果,但初步数据可能会在那之前公布。E6U世界播

© 2016 世界播 www.shijiebobao.com 中国互联网举报中心 京ICP证140141号 鄂ICP备18018000号-1
违法和不良信息举报: